December 5, 1991New England Journal of Medicine
Adenosine and Supraventricular Tachycardia
Key result
Intravenous adenosine is increasingly considered as an alternative to verapamil as first-line therapy to terminate paroxysmal supraventricular tachycardia.
Why the study?
Does intravenous adenosine improve termination of paroxysmal supraventricular tachycardia in humans?
Population
Humans with supraventricular arrhythmias / paroxysmal supraventricular tachycardia
Comparison
Intravenous adenosine vs Verapamil
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports adenosine consideration for paroxysmal supraventricular tachycardia termination; leaves open need for direct randomized comparisons to verapamil.
Structured PICO
Does intravenous adenosine improve termination of paroxysmal supraventricular tachycardia in humans?
P
Population
Humans with supraventricular arrhythmias / paroxysmal supraventricular tachycardia
I
Intervention
Intravenous adenosine
C
Comparator
Verapamil
O
Outcome
Termination of paroxysmal supraventricular tachycardia
Adenosine is increasingly considered as a first-line alternative to verapamil for terminating paroxysmal supraventricular tachycardia.
Cite This Study
Camm et al. (1991) conducted a review in Supraventricular Tachycardia. Adenosine vs. Verapamil was evaluated. Intravenous adenosine is increasingly considered as an alternative to verapamil as first-line therapy to terminate paroxysmal supraventricular tachycardia.